The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ATARA BIOTHERAPEUTICS INC COM 046513107 9,290 1,000,000 SH   DFND   1,000,000 0 0
CARDLYTICS INC COM 14161W105 35,121 638,800 SH   DFND   638,800 0 0
CAREMAX INC COM CL A 14171W103 3,175 425,000 SH   DFND   425,000 0 0
CARVANA CO CL A 146869102 48,312 405,000 SH   DFND   405,000 0 0
SEA LTD SPONSORD ADS 81141R100 41,927 350,000 SH   DFND   350,000 0 0
VANECK ETF TRUST VANECK RUSSIA ET 92189F403 283 50,000 SH   DFND   50,000 0 0